Gateway Traditional Grant Program
Gateway Traditional Grant Program supports researchers at institutions worldwide to conduct early-phase cancer treatment trials that center patients and could change the standard of care.
Browse similar grants
Funder: Gateway for Cancer Research
Due Dates: November 6, 2026 (LOI; tentative, 12 p.m. CT) | Per invitation (full application)
Funding Amounts: $200,000–$1.5 million; typically 2–5 years
Summary: Supports early-phase clinical trials for cancers of all types at institutions worldwide.
Key Information: A letter of intent precedes a full grant application, which is submitted by invitation.
Description
Gateway for Cancer Research funds early-phase clinical trials for cancers of all types at institutions around the world through its Traditional Grant Program. The Chicago-based nonprofit focuses on patient-centered Phase I and Phase II cancer trials with the potential to change the standard of care.
Gateway supports treatment-based studies, including investigational therapies, new indications, treatment de-escalation, toxicity mitigation, predictive biomarkers with a therapeutic component, and integrative medicine. Its patient-centered approach emphasizes feedback from patients and advocates, quality of life, and the burden of treatment on patients and caregivers.
